Patent · US Active

Method of generating skeletal muscle stem cells from pluripotent cells

US11306287B1 · kind B1 · utility

0Cited by

0References

4Claims

0Family size

Assignee

Regents of the University of Minnesota · US

Inventors

Michael Kyba · Minneapolis, US
Sun Kin Sunny Chan · Windom, US
Robert W. Arpke · Windom, US

Key dates

Filing date	Jun 16, 2017
Grant date	Apr 19, 2022
Priority date	—
Expiry date	Dec 18, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2510/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions and methods of the invention are directed to the formation and use of teratoma-derived skeletal muscle stem cells. In one embodiment, the teratoma-derived skeletal muscle stem cells improve muscle contractile force (definition “functional”) when administered to a patient in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.